Serina Therapeutics, Inc.
SER
$3.79
-$0.02-0.53%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -152.87% | -79.67% | 91.77% | -311.44% | -303.06% |
| Total Depreciation and Amortization | -27.08% | 2.11% | 82.35% | 115.56% | 43.57% |
| Total Amortization of Deferred Charges | -97.63% | -95.14% | 1,368.18% | -- | -- |
| Total Other Non-Cash Items | 80.45% | -981.33% | -311.32% | 59.34% | 70.37% |
| Change in Net Operating Assets | 170.27% | 146.02% | -1,104.73% | -4,193.83% | -2,759.87% |
| Cash from Operations | -32.86% | -48.95% | -494.56% | -592.12% | -259.57% |
| Capital Expenditure | 26.44% | 73.40% | 98.46% | 95.63% | 80.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 26.44% | 73.40% | 98.46% | 95.63% | 80.39% |
| Total Debt Issued | 71.26% | -95.97% | -73.21% | -69.87% | -78.82% |
| Total Debt Repaid | 99.44% | 95.11% | -210.00% | -250.00% | 95.13% |
| Issuance of Common Stock | 39.50% | 12.64% | 52,515.79% | 66,566.67% | 26,075.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,358.75% | 1,358.75% | 1,358.75% | -- | -- |
| Cash from Financing | 168.88% | 93.02% | 469.14% | 31.24% | -19.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.91% | 97.20% | -288.32% | -155.69% | -169.28% |